BCAM
REGN icon

Boston Common Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,343
Closed -$17.3M 312
2025
Q1
$17.3M Buy
27,343
+5,525
+25% +$3.5M 0.53% 70
2024
Q4
$15.5M Sell
21,818
-7,258
-25% -$5.17M 0.45% 84
2024
Q3
$30.6M Sell
29,076
-3,296
-10% -$3.46M 0.8% 28
2024
Q2
$34M Sell
32,372
-2,009
-6% -$2.11M 0.87% 22
2024
Q1
$33.1M Sell
34,381
-8,271
-19% -$7.96M 0.79% 38
2023
Q4
$37.5M Sell
42,652
-1,790
-4% -$1.57M 0.85% 34
2023
Q3
$36.6M Sell
44,442
-4,096
-8% -$3.37M 0.87% 30
2023
Q2
$34.9M Sell
48,538
-2,689
-5% -$1.93M 0.74% 39
2023
Q1
$42.1M Sell
51,227
-3,140
-6% -$2.58M 0.88% 28
2022
Q4
$39.2M Buy
54,367
+474
+0.9% +$342K 1.88% 5
2022
Q3
$37.1M Sell
53,893
-5,539
-9% -$3.82M 1.95% 5
2022
Q2
$35.1M Buy
59,432
+16,713
+39% +$9.88M 1.75% 9
2022
Q1
$29.8M Buy
42,719
+647
+2% +$452K 1.29% 18
2021
Q4
$26.6M Buy
42,072
+312
+0.7% +$197K 1.07% 28
2021
Q3
$25.3M Buy
41,760
+189
+0.5% +$114K 1.09% 29
2021
Q2
$23.2M Buy
41,571
+16,466
+66% +$9.2M 1% 36
2021
Q1
$11.9M Buy
25,105
+13,467
+116% +$6.37M 0.75% 44
2020
Q4
$5.62M Buy
11,638
+536
+5% +$259K 0.39% 78
2020
Q3
$6.22M Sell
11,102
-56
-0.5% -$31.3K 0.59% 51
2020
Q2
$6.96M Sell
11,158
-273
-2% -$170K 0.74% 44
2020
Q1
$5.58M Sell
11,431
-4,445
-28% -$2.17M 0.79% 45
2019
Q4
$5.96M Sell
15,876
-619
-4% -$232K 0.69% 54
2019
Q3
$4.58M Sell
16,495
-670
-4% -$186K 0.57% 69
2019
Q2
$5.37M Buy
17,165
+4,298
+33% +$1.35M 0.67% 57
2019
Q1
$5.28M Sell
12,867
-266
-2% -$109K 0.69% 57
2018
Q4
$4.91M Buy
13,133
+2,815
+27% +$1.05M 0.72% 53
2018
Q3
$4.17M Sell
10,318
-1,181
-10% -$477K 0.52% 74
2018
Q2
$3.97M Sell
11,499
-475
-4% -$164K 0.49% 73
2018
Q1
$4.12M Buy
11,974
+123
+1% +$42.4K 0.49% 76
2017
Q4
$4.46M Buy
11,851
+266
+2% +$100K 0.53% 74
2017
Q3
$5.18M Sell
11,585
-85
-0.7% -$38K 0.65% 64
2017
Q2
$5.73M Sell
11,670
-3,323
-22% -$1.63M 0.75% 50
2017
Q1
$5.81M Buy
14,993
+3,295
+28% +$1.28M 0.79% 40
2016
Q4
$4.29M Buy
11,698
+106
+0.9% +$38.9K 0.63% 58
2016
Q3
$4.66M Buy
11,592
+2,431
+27% +$977K 0.25% 121
2016
Q2
$3.2M Buy
9,161
+4,373
+91% +$1.53M 0.18% 144
2016
Q1
$1.73M Buy
+4,788
New +$1.73M 0.1% 158